ストックスクリーナーアプリを入手
1.88
1.62%
0.03
アフターアワーズ：
1.88
前日終値:
$1.85
開ける：
$1.82
24時間の取引高:
542.09K
Relative Volume:
0.35
時価総額：
$175.07M
収益：
$34.48M
当期純損益:
$-102.07M
株価収益率:
-1.2877
EPS:
-1.46
ネットキャッシュフロー:
$-104.90M
1週間 パフォーマンス:
+0.53%
1か月 パフォーマンス:
-17.54%
6か月 パフォーマンス:
+51.61%
1年 パフォーマンス:
-14.93%
1日の値動き範囲:
$1.8001
$1.89
1週間の範囲:
$1.73
$1.965
52週間の値動き範囲:
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
名前
Caribou Biosciences Inc
セクター
電話
510-982-6030
住所
2929 7TH STREET, SUITE 105, BERKELEY
CRBU を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.88 | 174.14M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 開始されました | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 開始されました | Evercore ISI | Outperform |
| 2023-07-11 | 開始されました | Truist | Buy |
| 2022-02-18 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-30 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-15 | アップグレード | Citigroup | Neutral → Buy |
| 2021-08-17 | 開始されました | BofA Securities | Buy |
| 2021-08-17 | 開始されました | Citigroup | Neutral |
| 2021-08-17 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Caribou Biosciences Inc (CRBU) 最新ニュース
Chart Analysts Warn of Resistance Near Caribou Biosciences Inc. PriceJuly 2025 Patterns & Free Low Drawdown Momentum Trade Ideas - beatles.ru
Caribou Biosciences reports Q2 EPS (35c), one estimate (42c) - MSN
Momentum Screeners Rank Caribou Biosciences, Inc. in Top 5 TodayJuly 2025 Update & Low Risk Growth Stock Ideas - thegnnews.com
Caribou Biosciences Inc. Pullback Analyzed — Is It Time to Exit2025 Sector Review & Short-Term High Return Ideas - kangso.co.kr
Caribou Biosciences Inc.’s Price Action Aligns with Quant SignalsWeekly Trade Review & AI Powered Buy/Sell Recommendations - beatles.ru
How does Caribou Biosciences Inc. score in quality rankingsCPI Data & Expert Verified Movement Alerts - 선데이타임즈
Is Caribou Biosciences Inc. Forming a Bottom PatternGlobal Markets & Reliable Entry Point Alerts - metal.it
Truist Financial analyst assigns Buy rating to Caribou Biosciences with $3.50 price target. - AInvest
RBC Capital Maintains Buy Rating for Caribou Biosciences with $10 Price Target - AInvest
Caribou Biosciences: Strong Clinical Progress and Financial Health Justify Buy Rating with $3.00 Target - AInvest
Caribou Biosciences: Promising Clinical Progress and Strong Financial Position Justify Buy Rating - TipRanks
Caribou Biosciences Reports Wider Q2 Loss Amid Increased R&D Spending - AInvest
Caribou Biosciences Reports Increased Losses Amid R&D Efforts - TipRanks
Navigating the Storm: Caribou Biosciences' Strategic Rebalancing and the Road to Gene-Editing Dominance - AInvest
Caribou Biosciences earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Caribou Biosciences Q2 2025: $184mln cash, H2 2027 funding, CB-010 & CB-011 data in H2 2025. - AInvest
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Is Caribou Biosciences Inc. Forming a Consolidation BaseTrade Setups With Clear Risk Limits Highlighted - beatles.ru
Caribou Biosciences CRBU Q2 2025 Earnings Preview Downside Risk Amid Clinical Trial Delays - AInvest
Sentiment Tools Show Shift in Trader Mood on Caribou Biosciences Inc.Exit Ready Momentum Stock Watchlist Expanded - beatles.ru
Published on: 2025-08-05 08:29:24 - metal.it
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU - ACCESS Newswire
Caribou Biosciences Inc. Price Targets Raised After ReboundWeekly Hot Picks With Buy Confidence Released - metal.it
What analysts say about Caribou Biosciences Inc. stockInvest confidently with professional advice - Jammu Links News
Caribou Biosciences Inc. Stock Analysis and ForecastTremendous growth potential - Jammu Links News
What makes Caribou Biosciences Inc. stock price move sharplyMaximize your returns with smart trade entries - Jammu Links News
Is Caribou Biosciences Inc. stock overvalued or undervaluedBuild wealth with steady, reliable stocks - Jammu Links News
What are the latest earnings results for Caribou Biosciences Inc.Achieve consistent double-digit growth rates - Jammu Links News
How does Caribou Biosciences Inc. compare to its industry peersBuild wealth steadily with expert advice - Jammu Links News
Is it the right time to buy Caribou Biosciences Inc. stockAchieve breakthrough investment performance - Jammu Links News
How strong is Caribou Biosciences Inc. company’s balance sheetInvest in high-yield stocks with confidence - Jammu Links News
Caribou Biosciences Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Caribou Biosciences Inc. stock prediction for this weekPortfolio Diversification Stock Ideas From Experts - metal.it
How Interest Rate Changes Impact Caribou Biosciences Inc. Stock PerformanceLong Hold Safe Return Strategy Reviewed - metal.it
Why Caribou Biosciences Inc. stock attracts strong analyst attentionTechnical Entry Strategy for Beginners Explained - beatles.ru
How many analysts rate Caribou Biosciences Inc. as a “Buy”Earnings Report Entry Points For Fast Growth - Jammu Links News
Why is Caribou Biosciences Inc. stock attracting strong analyst attentionHigh-velocity gains - Jammu Links News
What institutional investors are buying Caribou Biosciences Inc. stockMaximize returns with strategic trading plans - Jammu Links News
What is Caribou Biosciences Inc. company’s growth strategyCapitalize on fast-growing investment opportunities - jammulinksnews.com
Published on: 2025-07-28 05:44:44 - Jammu Links News
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Caribou Biosciences Inc (CRBU) 財務データ
収益
当期純利益
現金流量
EPS
Caribou Biosciences Inc (CRBU) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MCCLUNG BARBARA G | Chief Legal Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
443,502 |
| Khan Ruhi Ahmad | Chief Business Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
66,936 |
| Kanner Steven | Chief Scientific Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
431,556 |
| Ryali Sriram | Chief Financial Officer |
Jan 29 '25 |
Buy |
1.42 |
17,360 |
24,651 |
17,360 |
1.38%
0.27%
大文字化:
|
ボリューム (24 時間):